Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
"Precursor T-Cell Lymphoblastic Leukemia-Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.
MeSH Number(s)
C04.557.337.428.600.620
C15.604.515.560.600.620
C20.683.515.528.600.620
Concept/Terms
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T Cell Lymphoblastic Leukemia Lymphoma
- Leukemia, Lymphoblastic, Acute, T-Cell
- Leukemia, Lymphocytic, Acute T Cell
- Leukemia, Lymphocytic, Acute, T-Cell
- Leukemia, T-Cell, Acute
- Lymphoblastic Leukemia, Acute, T Cell
- Lymphoblastic Leukemia, Acute, T-Cell
- Lymphocytic Leukemia, T Cell, Acute
- Lymphocytic Leukemia, T-Cell, Acute
- Precursor T-Cell Lymphoblastic Leukemia
- Precursor T Cell Lymphoblastic Leukemia
- Precursor T-Cell Lymphoblastic Lymphoma
- Precursor T Cell Lymphoblastic Lymphoma
- T-ALL
- T-Cell Leukemia, Acute
- Acute T-Cell Leukemia
- Acute T-Cell Leukemias
- Leukemia, Acute T-Cell
- Leukemias, Acute T-Cell
- T Cell Leukemia, Acute
- T-Cell Leukemias, Acute
- T-Lymphocytic Leukemia, Acute
- Acute T-Lymphocytic Leukemia
- Acute T-Lymphocytic Leukemias
- Leukemia, Acute T-Lymphocytic
- Leukemias, Acute T-Lymphocytic
- T Lymphocytic Leukemia, Acute
- T-Lymphocytic Leukemias, Acute
- Leukemia, Lymphoblastic, Acute, T Cell
Below are MeSH descriptors whose meaning is more general than "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma".
Below are MeSH descriptors whose meaning is more specific than "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma".
This graph shows the total number of publications written about "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma" by people in Harvard Catalyst Profiles by year, and whether "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 3 | 1 | 4 |
2009 | 8 | 2 | 10 |
2010 | 9 | 2 | 11 |
2011 | 11 | 4 | 15 |
2012 | 7 | 3 | 10 |
2013 | 6 | 1 | 7 |
2014 | 21 | 4 | 25 |
2015 | 9 | 0 | 9 |
2016 | 6 | 1 | 7 |
2017 | 12 | 6 | 18 |
2018 | 12 | 0 | 12 |
2019 | 4 | 0 | 4 |
2020 | 10 | 2 | 12 |
2021 | 7 | 0 | 7 |
2022 | 11 | 0 | 11 |
2023 | 7 | 0 | 7 |
2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma" by people in Profiles.
-
Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia. Blood Adv. 2024 01 09; 8(1):23-36.
-
DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemia. Blood Adv. 2023 11 14; 7(21):6685-6701.
-
Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma. Clin Cancer Res. 2023 Nov 14; 29(22):4613-4626.
-
Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials. J Clin Oncol. 2023 Nov 10; 41(32):5025-5034.
-
BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia. Blood Adv. 2023 06 27; 7(12):2917-2923.
-
Pdx1 expression in hematopoietic cells activates Kras-mutation to drive leukemia in KC (Pdx1-Cre; LSL-KrasG12D/+) mice. Leuk Lymphoma. 2023 06; 64(6):1112-1122.
-
Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia. Blood Adv. 2023 04 11; 7(7):1092-1102.
-
Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials. Lancet Haematol. 2023 Feb; 10(2):e129-e141.
-
Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia. Blood. 2022 10 27; 140(17):1891-1906.
-
Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/KMT2A Rearrangements in a Modern Therapy Era: A Retrospective International Study. J Clin Oncol. 2023 03 01; 41(7):1404-1422.